Company Announcements

In December 2018, Scailyte raised CHF 2.75 million ($2.75 million) in seed funding. Scailyte develops AI-based software for analysis of complex single-cell data to enhance biomedical research, pharmaceutical discovery and precision diagnostics. The company’s software will launch this year.

In January, Verily, an Alphabet company, announced a $1 billion investment round, led by Silver Lake. Verily is a life sciences research and engineering organization focused on improving health care outcomes by applying the latest scientific and technological advances to significant problems in health and biology.

Molecular simulations firm Schrödinger closed a $85 million round in January, co-led by the Bill and Melinda Gates Foundation Trust and WuXi AppTec’s Corporate Venture Fund.

In January, MedEngine, a company specialized in high-quality medical data science services, and BC Platforms, a provider of genomic data management and analytics, entered into a major strategic alliance to create turnkey research solutions for the pharmaceutical and health sectors. The alliance brings together BC Platform’s global network of biobanks and MedEngine’s expertise in medical research.

FACIT, a business accelerator for Ontario oncology innovations, announced in January a follow-on investment in DNAstack, a provider of cloud-based genomic data sharing, access and management. DNAstack currently has 20 employees.

MediSapiens, a developer and provider of genomic, biomedical and health data solutions, partnered in January with Modul-Bio, a provider of solutions for biological sample management, Biobank Information Management Systems (BIMS) and collaborative tools for sharing biological sample collections.

In January, Scilligence, a provider of mobile cheminformatics and bioinformatics for the life sciences industry, joined the Accenture research platform open partner ecosystem. Accenture’s project has been developed in collaboration with Merck and Amazon Web Services to enhance innovation and collaboration between life science companies and software providers.

Eagle Genomics, a microbiome discovery platform company, closed a $3.5 million investment in January, led by the Environmental Technologies Fund.

In February, Eagle Genomics was selected to join the latest cohort of the Microsoft AI Factory.

In February, scientific informatics solutions and services firm Dotmatics and TetraScience, which provides a data platform for life sciences R&D, formed a strategic partnership. As part of the partnership, TetraScience has built a Dotmatics data integration. The Dotmatics suite is now available as both a data source and data consumer via the TetraScience Integration Engine.

Genedata, a provider of advanced software solutions for biopharmaceutical R&D, announced in February that scientific instrument company Bruker has become a Genedata Ready-to-Run partner. Bruker will collaborate with Genedata to offer standardized integrations with the Genedata Biopharma Platform. Initial Bruker integrations include the Bruker SPR32 system and rapifleX MPP MALDI TOF/TOF MS.

In February, DNAnexus closed a $68 million financing, which will support the deployment of DNAnexus Apollo, an advanced platform for multi-omics and clinical data exploration, analysis and discovery.

Autoscribe Informatics appointed NV Genomics as a distributor in India in February for the Matrix family of LIMS.

In February, biomedical data science company Seven Bridges announced it achieved 260% all-commodity volume growth in 2018 and maintained a 95% renewal rate.


Product Introductions

IOMICS released in December 2018 its first cloud-deployed analytics service, ASPEN, based on its FUSION Analytics Platform. ASPEN allows every bench scientist to automatically mine and model complex multiscale datasets to identify molecular signatures of pathogenic processes and disease progression critical to drug development, companion diagnostics and personalized patient profiling.

In January, CloudLIMS released an Instrument Module for its LIMS. The Instrument Module is for testing laboratories such as food and beverage, cannabis, clinical, and environment, enabling them to achieve ISO/IEC 17025:2017 accreditation. Additionally, it helps a laboratory monitor the status of its equipment and assure that an instrument is properly calibrated and ready to use for conducting tests

Certara launched in January v18 of its Simcyp Population-based Simulator. The Simulator’s permeability-limited tumor models now combine knowledge of the tumor composition with the drug’s physicochemical properties to simulate the distribution of small molecule drugs or biologics.

Genedata launched in January the new web-based Genedata Screener 16, featuring a completely redesigned user interface enabling a fully interactive and intuitive review of entire screening campaigns in the browser.

In February, Genedata released a new Request Management Module, which improves operational efficiency and monitors overall R&D operations by supporting the full life cycle of task scheduling. Used to submit and track requests from initiation through completion, it manages intergroup communications and centrally documents project progression in real time.

In February, analytics firm Clarivate Analytics introduced Cortellis Cloud, an integrated, scalable technology platform that serves as a single point of access to Cortellis, the company’s suite of life science intelligence solutions.

Clarivate Analytics, which offers scientific information products, announced in February a global agreement with Bioinfogate, a health care data science organization, to cross-link the OFF-X translational safety intelligence portal with Cortellis pre-clinical intelligence.

FreeLIMS released in February a new version of its free FreeLIMS software. New features and improved features include copying ability from parent to aliquot, pool samples to create derivative or aliquot, and import test results of samples tested for multi-analytes.


Sales and Orders of Note                                                                                      

STRmix in January announced five new customers, the South Carolina Law Enforcement Division, the Colorado Bureau of Investigation, Bode Cellmark Forensics, the Nebraska State Patrol and the University of Nebraska Medical Center Human DNA Identification Laboratory. The STRmix forensic software for resolving mixed DNA profiles is now being used by 43 federal, state and local agencies in the US.

Elsevier, the information analytics business specializing in science and health, announced in February that Lundbeck, a global pharmaceutical company specializing in brain diseases, has selected Elsevier’s Reaxys and Reaxys Medicinal Chemistry to support the ambitions of its research organization and accelerate data sharing and mining.

< | >